February 2022

Stimulation Approaches to Epilepsy Treatment

February 15, 2022

NeuroPathways

With one-third of the 3.4 million US patients with epilepsy currently experience drug-resistant epilepsy, creating an urgent need for novel intervention strategies, such as stimulation approaches.

Parkinson Disease Subtyping: Are We There Yet?

February 15, 2022

Features

Heterogeneity suggests that identifying different types of Parkinson disease could improve patient management, the understanding of underlying disease mechanisms, and the development of target-specific therapies.

Genetic Neurodegenerative Disorders: Close to a Symptom-Free Life?

February 11, 2022

Letter From the Editor

Although we have entered the age of genetically targeted therapies in the neuromuscular clinic, there are many unresolved clinical, economic, and ethical questions that require extensive further research.